Chiropractic Economics
FEBRUARY 27, 2025
The American Chiropractic Association (ACA) Council on Chiropractic Pediatrics has launched its 2025-2026 hybrid program, a 300-hour course of study that prepares doctors of chiropractic for the pediatrics diplomate certification exam. To learn more, visit acatoday.org.
Chiropractic Economics
AUGUST 4, 2024
The benefits of low-level laser therapy for peak athletic performance: An example At APEX Brain Centers, we harness the power of all three light sources and are realizing the treatment times for both injury and peak athletic performance being dramatically reduced. We can’t wait to see what he does in 2026. as quickly as possible.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
OrthoSpineNews
APRIL 10, 2025
This transaction is part of SpineGuard’s objective of reaching operational breakeven by the end of 2026. In addition, this transaction will enable us to significantly lighten our cost structure, as such it is an important catalyst for reaching our goal of operational breakeven by the end of 2026. BOULDER, Co., Ciaran Bolger, M.D.,
Orthopedic Principles
MARCH 28, 2025
Courtesy: Prof Michael Hantes, ESSKA 1st Vice President Ivory Orange Modern Meet Our Team Instagram Post – 1 Lecture Topic: Osteochondritis Dissecans of the Knee Aim: Define the treatment algorithm for this disease. Treatment depends on: Age, lesion size, symptoms, and patient expectations. Avoidance of high-impact sports.
OrthoSpineNews
JANUARY 29, 2025
OrthoPreserve’s implant addresses a significant treatment gap that exists due to the poor outcomes of the standard of care for meniscus tears, a partial meniscectomy, which removes the damaged tissue. OrthoPreserve’s proprietary technology has the potential to disrupt the standard of care and displace more invasive treatments.
OrthoSpineNews
MARCH 31, 2025
Over $20M raised in Q1 with nearly $15M cash on hand No debt, no preferred equity, and no warrants with strike prices near the current market Nasdaq compliant: fully meets bid price and shareholder equity requirements Pivotal CLARITY trial fully funded with initial interim results expected in Q2 2026 BROOMFIELD, Colo.,
OrthoSpineNews
APRIL 4, 2025
The investments will fuel the companys continued growth and the launch of four groundbreaking 3D printed product lines in 2025 and 2026. This funding allows us to further scale our technology, expand access to truly personalized care, and continue setting new standards in orthopedic treatment.
Expert insights. Personalized for you.
130 
Let's personalize your content